Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Aug 13, 2024 | Option Exercise | $73.60 | 14,100 | 1,037,760 | 45,628 | Aug 15, 2024, 05:12 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Aug 13, 2024 | Sale | $150.38 | 14,100 | 2,120,347 | 31,528 | Aug 15, 2024, 05:12 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Jul 16, 2024 | Option Exercise | $73.60 | 900 | 66,240 | 32,428 | Jul 18, 2024, 04:45 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Jul 16, 2024 | Sale | $150.04 | 900 | 135,037 | 31,528 | Jul 18, 2024, 04:45 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 14, 2024 | Option Exercise | $73.60 | 15,000 | 1,104,000 | 46,528 | May 16, 2024, 04:40 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 14, 2024 | Sale | $135.66 | 15,000 | 2,034,827 | 31,528 | May 16, 2024, 04:40 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 15, 2024 | Option Exercise | $73.60 | 15,000 | 1,104,000 | 46,528 | May 16, 2024, 04:40 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 15, 2024 | Sale | $140.24 | 15,000 | 2,103,609 | 31,528 | May 16, 2024, 04:40 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 13, 2024 | Sale | $132.85 | 1,352 | 179,612 | 31,528 | Feb 15, 2024, 05:27 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 06, 2024 | Sale | $142.19 | 1,280 | 182,000 | 29,434 | Feb 08, 2024, 07:12 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 08, 2024 | Sale | $134.21 | 980 | 131,529 | 30,314 | Feb 08, 2024, 07:12 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Jan 31, 2024 | Sale | $140.72 | 1,283 | 180,539 | 28,284 | Feb 02, 2024, 07:00 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Aug 21, 2023 | Sale | $107.39 | 2,132 | 228,958 | 27,131 | Aug 23, 2023, 07:58 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 08, 2023 | Sale | $104.19 | 980 | 102,110 | 25,213 | Feb 08, 2023, 07:16 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 06, 2023 | Sale | $105.67 | 1,280 | 135,253 | 22,507 | Feb 08, 2023, 07:16 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 07, 2023 | Sale | $102.40 | 26,328 | 2,696,107 | 35,824 | Feb 08, 2023, 07:16 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Jan 31, 2023 | Sale | $109.98 | 1,283 | 141,108 | 21,357 | Feb 02, 2023, 04:53 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 07, 2022 | Sale | $80.79 | 3,310 | 267,428 | 19,325 | Feb 09, 2022, 06:51 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 08, 2022 | Sale | $79.65 | 980 | 78,058 | 20,204 | Feb 09, 2022, 06:51 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Dec 01, 2021 | Sale | $82.59 | 1,645 | 135,852 | 16,349 | Dec 03, 2021, 05:02 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 08, 2021 | Sale | $116.82 | 2,910 | 339,942 | 14,869 | Feb 09, 2021, 09:30 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Dec 01, 2020 | Sale | $94.66 | 1,645 | 155,721 | 11,494 | Dec 02, 2020, 04:12 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Nov 12, 2020 | Sale | $90.74 | 2,257 | 204,810 | 10,014 | Nov 16, 2020, 06:02 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Aug 05, 2020 | Sale | $118.90 | 2,257 | 268,355 | 7,983 | Aug 07, 2020, 06:22 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 07, 2020 | Sale | $110.21 | 15,000 | 1,653,135 | 5,953 | May 11, 2020, 08:17 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | May 07, 2020 | Option Exercise | $73.60 | 15,000 | 1,104,000 | 20,953 | May 11, 2020, 08:17 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Apr 28, 2020 | Sale | $102.49 | 1,741 | 178,435 | 5,953 | Apr 30, 2020, 04:25 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Apr 24, 2020 | Sale | $99.52 | 1,934 | 192,467 | 7,694 | Apr 28, 2020, 08:32 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Feb 07, 2020 | Sale | $103.35 | 2,030 | 209,807 | 5,701 | Feb 11, 2020, 07:06 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Dec 02, 2019 | Sale | $116.33 | 1,645 | 191,360 | 3,876 | Dec 04, 2019, 06:06 PM | |
NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | Dec 03, 2018 | Sale | $90.00 | 1,178 | 106,020 | 1,947 | Dec 06, 2018, 05:54 PM |